Open access
Open access
Powered by Google Translator Translator

RCT | Intraperitoneal carboplatin achieves modest PFS gains in advanced ovarian cancer

25 Apr, 2023 | 14:24h | UTC

Intraperitoneal Carboplatin for Ovarian Cancer — A Phase 2/3 Trial – NEJM Evidence

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.